Cite
HARVARD Citation
Kurmasheva, R. et al. (2021). In vivo evaluation of the lysine‐specific demethylase (KDM1A/LSD1) inhibitor SP‐2577 (Seclidemstat) against pediatric sarcoma preclinical models: A report from the Pediatric Preclinical Testing Consortium (PPTC). Pediatric blood & cancer. 68 (11), p. n/a. [Online].